133 Results
Guidelines and Advice
Status: In-Review
ID: GL 2-26
Version: 3
ID: GL 2-26
Version: 3
Aug 2022
Guidelines and Advice
Status: Current
ID: 2-6
Version: 2
ID: 2-6
Version: 2
Sep 2022
Guidelines and Advice
Status: Current
ID: 4-13
Version: 3
ID: 4-13
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: 7-11
Version: 3
ID: 7-11
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: 7-16
Version: 4
ID: 7-16
Version: 4
Dec 2022
Guidelines and Advice
Status: Current
ID: GL 16-3
Version: 3
ID: GL 16-3
Version: 3
Mar 2022
Guidelines and Advice
Status: Archived
ID: 5-6c
ID: 5-6c
Nov 2000
Guidelines and Advice
Status: Current
ID: 5-11
Version: 2
ID: 5-11
Version: 2
Jan 2022
Guidelines and Advice
Status: Current
ID: 11-6
Version: 2
ID: 11-6
Version: 2
Feb 2022
Guidelines and Advice
Status: Current
ID: GL 1-22-A
Version: 2
ID: GL 1-22-A
Version: 2
Jul 2022
Drug
Other Name(s): Neulasta®
, Lapelga™
, Fulphila™
, Ziextenzo®
, Nyvepria™
Dec 2022
Drug
May 2022